P3 Health Partners reports Q1 net income $3M, raises FY 2026 adjusted EBITDA guidance to $20-60M

P3 Health Partners Inc.

2026-Q1 EPS reported $0.32 revenue$386,390,000

Q1 revenue $386M (+4% YoY); net income $3M vs net loss $44.2M prior year.
Adjusted EBITDA $25.8M ($81 PMPM); cites contract restructuring and operational redesign.
At-risk membership ~106,000, down 10% YoY due to intentional network rationalization.
Full-year 2026 adjusted EBITDA guidance raised to $20-$60M (midpoint $40M).
Medical margin $73.7M; excluding prior-year development and settlements $56.1M.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.